Jobs im Unternehmen "MorphoSys AG"
Kurzprofil zum Arbeitgeber
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development and commercialization of exceptional, innovative therapies for patients suffering from serious diseases, with a focus on cancer. Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed to the development of more than 100 product candidates, of which 27 are currently in clinical development. MorphoSys is listed on the Frankfurt Stock Exchange and NASDAQ under the symbol MOR. Headquartered in Planegg near Munich, Germany, the MorphoSys group includes the fully owned U.S. subsidiary MorphoSys US Inc. based in Boston, MA.